# LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient \(API\), Resveratrol: the COLO-PREVENT study

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [University of Leicester](/buyers/university-of-leicester/contract-awards)
- Contract winner: Catalent Nottingham Limited
- Award value: £1,057,433
- Tender value: £1,057,433
- Award date: 13 October 2021
- Published: 14 October 2021
- Contract start: 14 October 2021
- Contract end: 31 May 2031
- Stage: awarded
- Procurement category: services
- Notice ID: d9194bc4-e0fb-484f-80b3-7768a9e72fd9-476697
- OCID: ocds-b5fd17-571cd06f-c437-4ba2-bd04-1b30477471c7

## Description

LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient \(API\), Resveratrol: the COLO-PREVENT study

## Related contract awards

- [LUV01306 - DECIDE-TAD digital DST](/contracts/ocds-b5fd17-4d6858b0-9ded-44c9-9ae6-71969db29de6): University of Leicester
- [LUV01297 Framework agreement for the provision of next generation and third generation sequencing and sanger sequencing services](/contracts/ocds-b5fd17-bdfb99ad-ffee-4d3d-9c18-d322633afe52): University of Leicester
- [LUV01348 The supply and installation of a laser welder system](/contracts/ocds-b5fd17-b21f1ac7-3490-481d-a63e-026011a045f9): University of Leicester

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/d9194bc4-e0fb-484f-80b3-7768a9e72fd9-476697)